LYON, France--(BUSINESS WIRE)--POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative drugs to treat type 2 diabetes, today announced that the Company will make a presentation at the 28th Annual ROTH Conference to be held on March 13 - 16, 2016 at the Ritz Carlton Hotel, Dana Point, California.
